Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
LivaNova PLC LIVN
$46.68
-$0.33 (-0.71%)
На 18:00, 12 мая 2023
+52.10%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
2525487657.00000000
-
week52high
70.57
-
week52low
40.26
-
Revenue
1021800000
-
P/E TTM
-93
-
Beta
0.86193700
-
EPS
-1.58000000
-
Last Dividend
0.00000000
-
Next Earnings Date
01 авг 2023 г. в 10:59
Описание компании
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Goldman Sachs | Buy | Buy | 16 авг 2022 г. |
| Needham | Buy | Buy | 04 авг 2022 г. |
| Piper Sandler | Overweight | Overweight | 05 мая 2022 г. |
| Wolfe Research | Outperform | 06 апр 2022 г. | |
| UBS | Buy | Neutral | 24 февр 2022 г. |
| Needham | Buy | Buy | 02 ноя 2022 г. |
| Goldman Sachs | Buy | Buy | 23 ноя 2022 г. |
| Barclays | Equal-Weight | 21 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| McDonald Damien | D | 83749 | 2220 | 15 дек 2022 г. |
| Hutchinson Michael Damon | A | 9015 | 9015 | 15 дек 2022 г. |
| Shvartsburg Alex | D | 1226 | 613 | 15 дек 2022 г. |
| Shvartsburg Alex | D | 6584 | 289 | 15 дек 2022 г. |
| Shvartsburg Alex | A | 6873 | 613 | 15 дек 2022 г. |
| Story Brooke | A | 1725 | 1725 | 15 сент 2022 г. |
| Skeffington Keyna Pidcock | D | 0 | 300 | 15 сент 2022 г. |
| Skeffington Keyna Pidcock | D | 8090 | 141 | 15 сент 2022 г. |
| Skeffington Keyna Pidcock | A | 8231 | 300 | 15 сент 2022 г. |
| Hebbelinck Trui | D | 440 | 440 | 15 сент 2022 г. |
Новостная лента
Primecap Management Pumps Up LivaNova Position
GuruFocus
10 мая 2023 г. в 12:35
Media-shy investment firm PRIMECAP Management (Trades, Portfolio) revealed earlier this week it upped its stake in LivaNova PLC ( LIVN , Financial), which had an impact of 0.04% on the equity portfolio.
LivaNova PLC (LIVN) Q1 2023 Earnings Call Transcript
Seeking Alpha
07 мая 2023 г. в 11:48
LivaNova PLC (NASDAQ:LIVN ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development William Kozy - Chairman & Interim Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Financial Michael Polark - Wolfe Research Matthew Taylor - Jefferies Adam Maeder - Piper Sandler Mike Matson - Needham & Company Operator Good day ladies and gentlemen and welcome to the LivaNova PLC First Quarter of 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
LivaNova (LIVN) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research
03 мая 2023 г. в 09:07
LivaNova (LIVN) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.48 per share a year ago.
Strength Seen in LivaNova (LIVN): Can Its 12.7% Jump Turn into More Strength?
Zacks Investment Research
18 апр 2023 г. в 09:56
LivaNova (LIVN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
LivaNova (LIVN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Zacks Investment Research
15 мар 2023 г. в 11:28
After losing some value lately, a hammer chart pattern has been formed for LivaNova (LIVN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.